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Primary Sjögren Syndrome (pSS) is a multisystem autoimmune disease which mainly involves 
exocrine glands, such as salivary and lacrimal. Pathogenesis is not completely understood even if is 
distinguished by lymphocyte glands tissue infiltration, which leads to anatomical modification and 
hypofunction. Age at diagnosis is typically between 3rd and 5th decade. European incidence per year 
is 3 to 11 cases on 100.000 subjects, with a female-male ratio of 10:1 and a 0.01% e 0.72% prevalence. 
Diagnostic criteria are resumed in the 2016 ACR/EULAR Consensus of Classification Criteria 
for pSS, and are based on the sum of weighted scores applied to 5 items: anti-SSA/Ro antibody 
positivity, focus score of ≥1 foci/4 mm2, abnormal ocular staining, a Schirmer’s test result of ≤5 mm/5 
min and an unstimulated salivary flow rate (SFR) of ≤0.1 mL/minute. The prognosis of pSS is 
favorable with a patient’s life expectancy comparable with general population. Quality of life is 
reduced by the diverse manifestations of the disease. Cardiovascular disease, infections, solid 
tumors, and lymphoma are the main causes of death [1]. 
The aim of this pilot study is to compare the salivary metabolome of pSS and healthy controls 
(HC). Cases were selected from a cohort of pSS patients; age and sex matched HC were recruited 
from a cohort of volunteers. Strict inclusion and exclusion criteria were applied, in order to select the 
most homogeneous study population. To all recruited patients was asked to not eat, drink, smoke 
and use oral hygiene products one hour before saliva collecting. Whole unstimulated saliva was 
collected into a sterile Eppendorf. SFR was contextually evaluated. All samples were immediately 
frozen into liquid nitrogen and stored into −80 °C refrigerator until analysis. 
7 pSS and 6 HC female patients were recruited. All samples were centrifuged at 15,000 rpm/10 
min, 4 °C. 100 µL of buffer were added to 500 µL of supernatant; the solution was inserted in the 
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NMR tube of a Bruker Avance III HD 600 MHz spectrometer for the 1H-NMR analysis. 
Mono-dimensional and bi-dimensional measurements were performed using different pulse 
sequences such as Carr-Purcell-Meiboom-Gill (cpmg) and different correlation sequence such as 
COrrelation SpectroscopY (COSY) and Heteronuclear Single Quantum Coherence (HSQC) (Figure 1). 
Software aided data analysis were performed. 
33 metabolites were detected. An high metabolite variability was observed. Normalized 
spectral matrix multivariate statistical analysis (PCA and PLS-DA) returned interesting results, 
describing significant differences of metabolites expressions between groups (Figure 1). 
 
Figure 1. Partial Least Squares Discriminant Analysis (PLS-DA). Chemo-metric differences between 
groups emerged (SS vs. HC); algorithm supervised analysis showed separation of variables’ clusters 
(metabolites). 
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